Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v20-FR Version v9-FR
Language French French
Date Updated 2018-10-19 2018-08-31
Drug Identification Number 02320924 02320924
Brand name ALREX ALREX
Common or Proper name ALREX ALREX
Company Name BAUSCH & LOMB INC BAUSCH & LOMB INC
Ingredients LOTEPREDNOL ETABONATE LOTEPREDNOL ETABONATE
Strength(s) 0.2% 0.2%
Dosage form(s) SUSPENSION SUSPENSION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5 ml 5 ml
ATC code S01BA S01BA
ATC description ANTIINFLAMMATORY AGENTS ANTIINFLAMMATORY AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2018-09-07
Actual start date 2018-09-05
Estimated end date 2018-09-14
Actual end date 2018-10-18
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments